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a  b  s  t  r  a  c  t
Binding  of  host  immunoglobulin  is a  common  immune  evasion  mechanism  demonstrated  by microbial
pathogens.  Previous  work  showed  that the  malaria  parasite  Plasmodium  falciparum  binds  the  Fc-region  of
human IgM  molecules,  resulting  in  a  coating  of IgM on  the  surface  of  infected  erythrocytes.  IgM binding is
a  property  of  P.  falciparum  strains  showing  virulence-related  phenotypes  such  as  erythrocyte  rosetting.
The  parasite  ligands  for  IgM binding  are  members  of  the  diverse  P.  falciparum  Erythrocyte  Membrane
Protein  One  (PfEMP1)  family.  However,  little  is  known  about  the amino  acid sequence  requirements  for
IgM  binding.  Here  we  studied  an  IgM binding  domain  from  a rosette-mediating  PfEMP1  variant,  DBL4
of  TM284var1,  and  found  that  the  minimal  IgM binding  region  mapped  to  the  central  region  of the
DBL  domain,  comprising  all  of subdomain  2 and adjoining  parts  of  subdomains  1 and  3. Site-directedc-receptor
ar gene
BL domain
mutagenesis  of charged  amino  acids  within  subdomain  2, predicted  by molecular  modelling  to form  the
IgM binding  site,  showed  no  marked  effect  on IgM  binding  properties.  Overall,  this  study  identiﬁes  the
minimal  IgM  binding  region  of a PfEMP1  domain,  and  indicates  that the existing  homology  model  of
PfEMP1-IgM  interaction  is  incorrect.  Further  work  is  needed  to identify  the  speciﬁc  interaction  site for
indin
ublisIgM  within  the  minimal  b
©  2015  The  Authors.  P
. Introduction
Many pathogens have evolved to bind to a common site on the
c portion of immunoglobulin, however, the consequences of such
nteractions are largely unexplored [1]. Plasmodium falciparum,  the
ajor cause of severe malaria, is an example of such a pathogen
hat has been shown to bind to the Fc region of human IgM [2].
inding occurs during the asexual stage of the parasite life cycle
n the surface of infected Red Blood Cells (iRBCs) to a parasite-
erived ligand called P. falciparum Erythrocyte Membrane Protein
 (PfEMP1) [2], which is a variant surface antigen encoded by the
ar gene family. Each parasite has approximately 60 var genes in its
enome, with only one transcribed at a time per iRBC [3]. Switching
f var gene transcription leads to a change in the PfEMP1 variant
xpressed on the surface of the iRBC and is responsible for anti-
∗ Corresponding author. Fax: +44 1316506564.
E-mail address: Alex.Rowe@ed.ac.uk (J.Alexandra Rowe).
1 These authors contributed equally to this work.
2 Present address: UMR-S 1134, Inserm/Université Paris Diderot, Paris, France.
ttp://dx.doi.org/10.1016/j.molbiopara.2015.06.001
166-6851/© 2015 The Authors. Published by Elsevier B.V. This is an open access article ug  region  of PfEMP1.
hed  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
genic variation of malaria parasites [3]. PfEMP1 molecules are made
up of cysteine-rich adhesion domains called Duffy Binding Like
(DBL) and Cysteine-rich Inter-Domain Regions (CIDR) that bind to
a range of host receptors including CD36, Chondroitin Sulphate A
(CSA), InterCellular Adhesion Molecule-1 and Endothelial Protein C
Receptor [4]. The adhesion domains are further classiﬁed into sub-
types, DBL (, , , , ,  and x) and CIDR (, , ,  and PAM),
based on sequence similarity [5,6]. Only a minority of PfEMP1 vari-
ants show IgM binding activity, but IgM binding is linked to several
virulence-associated P. falciparum phenotypes such as rosetting
with uninfected RBC in severe childhood malaria [7] and binding
to CSA in placental malaria [8]. The molecular basis of IgM binding
by PfEMP1 is not fully understood, but current data suggest that
most IgM binding sites lie within speciﬁc DBL and DBL domains
[2,9–11].
Previously we  studied an IgM binding rosetting P. falciparum line
TM284R+, which is a culture-adapted parasite derived from a Thai
patient with cerebral malaria [12]. Rosetting is the binding of iRBC
to two  or more uninfected RBC, and is a PfEMP1-mediated parasite
virulence phenotype that is implicated in severe malaria [13]. Many
rosetting PfEMP1 variants bind IgM [14], and the IgM is thought
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Identiﬁcation of the minimal IgM binding region of the TM284var1 DBL4 domain.











[omain  boundaries and IgM binding properties of each DBL4 deletion construct. T
ines  (construct used in previous work [2]). Seven deletion constructs were made sp
nd  non-binding proteins are shown as white bars. (C) The minimal binding region 
esidues are highlighted by arrowheads. The ﬁve charged residues within subdoma
o strengthen and stabilise the rosettes [12,15]. We  identiﬁed the
fEMP1 variant expressed by IgM binding rosetting TM284R+ par-
sites as TM284var1, and showed that the IgM binding region is
he fourth DBL domain from the N-terminus, DBL4 [2] (Fig. 1A).
his domain was initially described as a DBL subtype, however,
ore recent analyses indicate that this domain is a DBL subtype
6]. Henceforth, we shall refer to this domain as TM284var1 DBL4.l length DBL4 domain (top bar) contains 16 cysteines as visualized by the dashed
g various regions of DBL4. Proteins that bind human IgM are shown as black bars,
4 (red). Subdomain (SD) 1 (yellow), 2 (blue) and 3 (grey) are shown, and cysteine
redicted to be involved in IgM binding are shown in bold.
In our previous work, we localised the PfEMP1-IgM binding
interaction site to the C3-C4 region of IgM Fc, and showed
that the same site on IgM is used by multiple different P. falci-
parum genotypes [2,16]. Although, a common site on the host IgM
molecule has been identiﬁed, the IgM binding site within a para-
site DBL domain has not yet been investigated further. The aim of
this study was to determine the minimal region within TM284var1
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is to investigate the role of speciﬁc amino acids within TM284var1
BL4 identiﬁed as possible IgM-interaction sites from homology
odelling.
. Materials and methods
.1. Deletion constructs and COS cell immunoﬂuorescence assays
Deletion constructs based on TM284var1 (Genbank accession
umber JQ684046) DBL4 were ampliﬁed and cloned into the pRE4
ector as described previously [9,17]. The amino acid boundaries
nd primers used are shown in Table S1. Immunoﬂuorescence
ssays (IFAs) were carried out as described previously [9]. Brieﬂy,
OS-7 cells were seeded in wells containing 12 mm coverslips
nd transfected with constructs using FuGene (Roche) according
o the manufacturer’s protocol. IFAs were carried out forty-eight
ours after transfection on cells that were washed with Phosphate
uffered Saline (PBS) and ﬁxed for 10 min  in PBS/2% formaldehyde.
ells were blocked for 1 h with PBS/5% Bovine Serum Albumin (BSA)
nd incubated with PBS containing 10 % pooled human serum as
 source of IgM for 1 h. Cells were washed in PBS/0.1% BSA and
ncubated for 1 h with either a mouse anti-human IgM monoclonal
ntibody (mAb) (AbD Serotec MCA  1662) or mouse mAb  DL6 (Santa
ruz Biotechnology sc-21719) diluted 1:1000 in PBS/0.1% BSA. DL6
etects the HSV-1 glycoprotein D tag at the C-terminal end of the
loned DBL domain [17]. Cells were washed in PBS/0.1% BSA and
ncubated with 1:6000 of Alexa Fluor 488-labelled goat anti-mouse
gG (Molecular Probes, A-11029) diluted in PBS/0.1% BSA for 45 min.
ells were washed for 10 min  with PBS/0.1% BSA, mounted on a
lide using Fluoromount-G (Southern Biotech) and viewed using a
eica DM LB2 ﬂuorescence microscope. The transfection efﬁciency
nd/or IgM binding was assessed by counting the percentage of
OS-7 cells showing positive surface ﬂuorescence with DL6 or anti-
gM mAb  in 10 ﬁelds with a 40x objective. The total number of
OS-7 cells per ﬁeld was counted using the auto-ﬂuorescence of
he cell nuclei to identify individual cells. The precise number of
ells counted differed in experiments with varying cell conﬂuence
80–100% conﬂuent), but at least 500 COS-7 cells per slide were
ounted in all cases. Positive cells were deﬁned as those showing
uorescence over the whole COS-7 cell surface as indicated in Fig.
1 and in our previously published work [2,9].
.2. Molecular modelling
The homology model of TM284var1 DBL4 was  constructed
ith the automated homology modelling tools in DeepView v.3.7
18] using the structure of 3D7var2CSA DBL6 (PDB accession code
WAU) as the template, as described previously [16].
.3. Expression and puriﬁcation of mutant DBL4 protein
Site-directed mutagenesis of TM284var1 DBL4 was  car-
ied out by two-step PCRs using mutagenic primers and
fx Platinum polymerase according to the manufacturer’s
rotocol (Invitrogen). The primers used for the E1663R
utant were 5′-caatgggagaaaacacgaaatgaagcacaaaaa-3′ and
′-tttttgtgcttcatttcgtgttttctcccattg-3′. The primers used for R1764E
utant were 5′-ttcctttttgtaaaagaaggaaaaggagatgga-3′ and 5′-
ccatctccttttccttcttttacaaaaaggaa-3′. The ﬁrst PCR ampliﬁed two
ragments from the wild type construct that was used as a
emplate. The two fragments contained overlapping complimen-
ary ends and included the mutation that would result in an
mino acid substitution. The second PCR used primers speciﬁc
or the outer borders (used initially to PCR wild type DBL4 of
M284var1) to amplify the overlapping fragments made from the
rst PCR. These primers were 5′-aaggatccaactgtgctgaaaaggttgct-3′ical Parasitology 201 (2015) 76–82
(normal forward) and 5′- aagctagcttacttacatttacaagcattacc-3′
(normal reverse). The resulting PCR product was  cloned into
the pET15b-modiﬁed vector [19]. The E1663R, R1764E double
amino acid mutant was generated using the E1663R construct as a
template and PCR was carried out with primers shown above for
R1764E. The resulting PCR product was  used as a template for a
second PCR with the normal forward and normal reverse primers
and subsequently cloned into the pET15b-modiﬁed vector. The
construct containing four mutations was generated in a similar
manner as described above. Firstly, the R1764E construct was
used as a template to introduce the E1665R and E1665R mutations
by PCR using the 5′-caatgggagaaaacacgaaatcgagcacaaaaa-3′ and
5′-tttttgtgctcgatttcgtgttttctcccattg-3′ primers. The resulting PCR
product containing E1663R, E1665R and R1764E mutations was
used as a template to introduce the fourth E1779K mutation
by PCR using the 5′-tttttaactttttcaaaacataaaaaatgtgga-3′ and
5′-tccacattttttatgttttgaaaaagttaaaaa-3′ primers and subsequently
cloned into the pET15b-modiﬁed vector. DNA sequencing con-
ﬁrmed the presence of mutations in the resulting constructs and
protein expression was  performed as described earlier [20]. Brieﬂy,
Escherichia coli Origami B cells (Novagen) were transformed and
grown to O.D. of 1.2 at 600 nm.  Bacterial cultures were induced
with a ﬁnal concentration of 1 mM IPTG and grown overnight at
25 ◦C in an orbital shaker. Bacterial pellets were harvested, soni-
cated and protein was puriﬁed from soluble lysate using Ni-NTA
metal afﬁnity chromatography. Fractions containing protein were
combined, concentrated using Amicon Ultra centrifugal ﬁlters
(Millipore) and further puriﬁed by size exclusion chromatography
on a Superdex 200 (16/60) column (GE Healthcare). Fractions were
collected and the presence of protein at the expected molecular
weight of approximately 58kDa was  assessed by SDS-PAGE (see
below). Fractions were concentrated and stored at −80 ◦C prior
to use in circular dichroism (CD) or Surface Plasmon Resonance
(SPR).
2.4. Characterisation of DBL4 mutants by SDS-PAGE and
Western blot
The purity of the eluted protein was  assessed by SDS-PAGE.
Five g of puriﬁed protein was  prepared in loading buffer under
non-reducing and reducing (5% -mercaptoethanol) conditions
and heated to 80 ◦C for 10 min. Five l of broad range pre-stained
marker (NEB) was run alongside the recombinant DBL4 proteins.
Electrophoresis was  carried out on 4–12% bis-Tris polyacrylamide
gradient gels with MES  SDS running buffer, and the gels were
stained with Simply Blue SafeStain using the manufacturer’s proto-
cols (Invitrogen). For the western blot, 5 g wild type and mutant
DBL domains were run on a 4–12% bis-Tris polyacrylamide gradient
gel with MOPS SDS running buffer (Life Technologies). Replicate
gels were either stained using Simply Blue SafeStain (Invitrogen)
or transferred onto a PVDF membrane using the iBlot gel trans-
fer device (Life Technologies). The membrane was probed with a
Penta His HRP-conjugated antibody (1/2000; Qiagen), and devel-
oped using Super Signal West Pico (Thermo Scientiﬁc).
2.5. Characterisation of DBL4 mutants by circular dichroism
(CD)
DBL4 recombinant proteins were dialysed in 50 mM phosphate
buffer (pH 7.2) overnight at 4 ◦C and concentration adjusted to
0.1 mg/ml. CD spectra were recorded with 300 l of DBL4 pro-
teins using a Chiracan-plus spectrometer (Applied Photophysics)
at 25 ◦C. A cell of 0.05 cm path length was  used and measurements
were recorded at 1 nm intervals between 190 and 260 nm at 1s
averaging time for each point. Ten consecutive measurements were
averaged and corrected against buffer alone. Results were normal-
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Table  1
Summary of transfection efﬁciency and IgM binding of TM284var1 DBL4 deletion
constructs expressed in COS-7 cells.
Construct Cysteines Transfection efﬁciencya (%) IgM bindingb (%)
1c E1481-T1952 C1–C16 10–15 8–12
2  K1595-H1839 C4–C11 15–20 10–15
3  K1595-E1814 C4–C10 25–30 10–15
4  K1595-L1799 C4–C9 20 0
5  K1595-E1773 C4–C8 15–20 0d
6 P1615-H1839 C6–C11 10–15 0d
7 P1615-E1814 C6–C10 10–15 0
8 Q1625-H1839 C7–C11 15–20 0
a Transfection efﬁciency was  determined by counting the percentage of COS-7
cells showing surface ﬂuorescence by IFA with mAb  DL6.
b IgM binding was determined by counting the percentage of COS-7 cells showing
surface ﬂuorescence by IFA using a mouse anti-human IgM mAb. Data from at least
2  experiments for each construct is shown.
c Construct used in previous study [2].





































Fig. 2. Homology model of TM284var1 DBL4.
The TM284var1 sequence starting from Glu1481 to Thr1952 was used to generate
a  model of DBL4 based on the structure of DBL6 of 3D7var2CSA as described
previously [16]. Amino acids 1595–1814, the minimal IgM binding region, are shown
therefore could be bacterial impurities or DBL fragments cleaved atot  all experiments (n = at least 3).
zed to mean molar differential coefﬁcient per amino acid residue
http://dichroweb.cryst.bbk.ac.uk/html/userguide.shtml).
.6. Surface Plasmon Resonance (SPR)
IgM (Calbiochem 401108) (25 g/ml) was immobilized onto the
urface of a GLC sensor chip (BioRad; ∼10,000 response units) at
H 5, using the manufacturer’s amine-coupling kit and protocol.
he binding of DBL4 wild type and mutants to human IgM was
easured using a ProteOn XP36 biosensor instrument (BioRad).
ecombinant proteins in 10 mM Tris pH 7.4, containing 140 mM
aCl, 2 mM CaCl2 and 0.005% Tween-20 at 25 ◦C were tested over a
ange of concentrations (600, 300, 150, 75, 37.5 and 18.75 nM)  at a
ow rate of 25 l/min. After each run the chip was  regenerated with
0 mM Glycine-HCl (pH 2.5). The responses of speciﬁc binding to
gM-coated channels were calculated by subtracting the response
btained from binding to an uncoated lane monitored simultane-
usly. The sensograms were ﬁtted using a 1:1 Langmuir kinetic
odel and the ProteOn Manager software was  used to derive the
alues for ka, kd and KD.
. Results
.1. Identiﬁcation of the minimal IgM binding region of DBL4
TM284var1)
We  previously showed that recombinant TM284var1 DBL4
amino acids Glu1481-Thr1952) containing 16 cysteine residues
construct 1) binds to human IgM [2]. We  made deletion constructs
ased on this domain, which we expressed on the surface of COS-7
ells, to identify the minimal region that could bind IgM. Construct
, containing 8 cysteine residues (C4-C11), and construct 3 contain-
ng 7 cysteine residues (C4-C10) bound IgM similarly to construct
 (Fig. 1B and Table 1). Deleting cysteine 10 resulted in a loss of IgM
inding (construct 4, C4–C9). The smaller constructs 5–8 also failed
o bind IgM. Therefore, the minimal IgM binding region is C4–C10
construct 3, Lys1595 to Glu1814).
DBL domains are composed of a core scaffold of alpha-helical
undles stabilised by disulphide bonds, and consist of three sub-
omains [21]. The minimal IgM binding region comprises all of
ubdomain 2 of TM284var1 DBL, with ﬂanking parts of subdomain and 3 (Fig. 1C). The minimal binding region is shown in orange in
 homology model of the TM284var1 DBL domain (Fig. 2).in  orange. Negatively charged amino acids postulated to bind IgM are shown in red
(Glu1663, Glu1665 and Glu1779, and positively charged residues in blue (Arg1764
and Lys1782).
3.2. Production of TM284var1 DBL4 mutants to investigate the
IgM binding site
We previously used homology modelling of the TM284var1
DBL4 domain [16] and human IgM [22] to construct a model of
the DBL4-IgM complex. The DBL-IgM docking model was gener-
ated under constraints that took into account the narrowness of
the IgM C3-C4 interdomain region and the position and lim-
ited solvent accessibility of the DBL domain in the context of the
entire PfEMP1 molecule [16]. In this model, the predicted interac-
tion site included ﬁve charged amino acid residues in subdomain
2 of DBL4 (Fig. 2) that were immediately adjacent to oppositely
charged residues in IgM, suggesting that these residues might be
important for the interaction. The deletion mutant experiments
in Fig. 1 conﬁrmed that subdomain 2 is essential for IgM binding,
consistent with a role for the ﬁve charged residues.
Therefore, to test the role in IgM binding of the charged residues
predicted by the model, we expressed mutant recombinant pro-
teins in E. coli and tested the ability of each mutant to bind human
IgM. In each mutant the key residue(s) were mutated to residues
showing the opposite charge. The proteins tested were single amino
acid mutants E1663R and R1764E, double mutant E1663R, R1764E
and quadruple mutant E1663R, E1665R, R1764E, E1779K. All pro-
teins were expressed as soluble his-tagged proteins in E. coli and
were puriﬁed using nickel afﬁnity chromatography followed by
size exclusion chromatography. The proteins were assessed by
SDS-PAGE and in each case showed a major band about 56 kDa
under non-reducing conditions, with a shift upon reduction con-
sistent with the presence of disulﬁde bonds in the recombinant
proteins (Fig. 3A). All proteins showed complex size exclusion chro-
matograms (an example is shown in Fig. S2) and contained some
smaller fragments in addition to the major species (Fig. 3A), pos-
sibly due to proteolytic degradation [23]. Western blotting with
an anti-his mAb  showed that all the proteins of approx. 50 kDa
and larger retained the N-terminal his-tag. However, the 27 and
23 kDa fragments were not recognised by the anti-his mAb, andthe N-terminus (Fig. S3).
We assessed the quality of the expressed proteins by circular
dichroism to test whether the recombinant DBL4 mutants and
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Fig. 3. Characterization of recombinant DBL4 mutant proteins.
(A) SDS-PAGE of puriﬁed wild type DBL4 and mutant proteins on 4–12% bis-Tris polyacrylamide gels. Five micrograms of proteins were used per lane and the broad range
pre-stained protein marker (NEB) was used as a reference. Predominant bands at approximately 56 kDa were observed under non-reducing conditions, which shifted upon
reduction, which is typical of DBL domains and characteristic of folded proteins with disulphide bonds. Lanes were as follows: (1) Wild type DBL4, (2) E1663R, (3) R1764E,
(4)  E1663R, R1764E and (5) E1663R, E1665R, R1784E, E1779K. (B) CD spectra of puriﬁed recombinant wild type and mutant DBL4 proteins. Minima near 208 and 222 nm
and  maximum near 190 nm indicate the presence of signiﬁcant -helical content.
Table 2
Secondary structure elements in wild type and mutant proteins predicted from circular dichroism.
Protein -Helices (%) -Parallel -sheets (%) Parallel -sheets (%) -Turns (%) Random-coils (%) Total secondary
elements (%)
DBL4 wild type 52 3.0 4.5 14.8 15.3 89.6
E1663R 58.2 2.6 3.4 14.4 9.8 88.4

















lE1663R, R1764E 68.9 0.8 
E1663R, E1665R, R1764E, E1779K 59.3 2.2 
ild type are comparable and show the characteristic secondary
tructure seen with other DBL proteins. All four mutants showed
 characteristic -helical signature at 208 and 222 nm,  similar to
he wild type protein (Fig. 3B). Deconvolution of the CD spectra
sing CDNN software (Applied Photophysics) showed similar dis-
ribution of secondary structure components for each recombinant
BL4 protein (Table 2), suggesting that the mutants show similar
verall DBL folds to the wild type. Furthermore, the CD spectra and
econdary structure predictions are highly similar to those reported
reviously for other DBL recombinant proteins [24,25].
.3. Binding of recombinant TM284var1DBL4 mutants to human
gMSurface Plasmon Resonance (SPR) was used to assess the bind-
ng of single (E1663R and R1764E), double (E1663R, R1764E) and
uadruple (E1663R, E1665R, R1764E, E1779K) mutants to immobi-
ized IgM. All mutants bound IgM similarly to the wild type (Fig. 4),.7 12.3 9.3 93.1
.6 14.2 16.1 91.0
with binding afﬁnities (KD) in the nanomolar range for all proteins
(Table 3). There were minor differences in KD between some of
the proteins, but further investigation with completely pure pro-
tein preparations would be required to determine the signiﬁcance
of these minor changes. All mutants containing R1764E showed
biphasic association and dissociation curves (Fig. 4). Fitting the data
to a model with two independent binding sites gave a KD simi-
lar to the value obtained for the single-site model, together with
a much tighter complex with no detectable dissociation over the
time course of the experiment (koff < 10−6 s−1, the lower limit of the
SPR machine). This suggests that a fraction of the R1764E protein
preparation bound irreversibly to the chip, probably due to small
amounts of aggregates. Critically, however, the rest of the protein
bound with similar kinetics to the wild type protein. Overall, the
SPR data show that the mutated residues do not play a major role
in binding human IgM, although further work would be needed to
exclude minor effects.
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Fig. 4. Binding of DBL4 mutants to human IgM by SPR.
SPR  sensograms showing wild type and mutant DBL4 recombinant proteins binding to human IgM. Proteins were diluted two-fold starting at 600 nM.  All six dilutions were
ﬂowed  at the rate of 25 l/min (200 s contact time and 200 s dissociation) and regenerated with Glycine-HCl (pH 2.5). Values obtained using an uncoated lane were subtracted
to  give speciﬁc binding data. All of the recombinant proteins that contain the R1764E mutation did not fully dissociate, suggesting that some protein may  be interacting
non-speciﬁcally to the chip. Two  independent experiments were carried out with similar results.
Table 3
Association rate (ka), dissociation rate (kd) and binding afﬁnity (KD) for DBL4 recom-
binant proteins.
Recombinant protein ka (M−1 s−1) kd (s−1) KD (nM)
Wild type 1.79 × 105 1.18 × 10−2 66.2
E1663R 1.29 × 105 1.48 × 10−2 115.0









One of the limitations of the current study was the difﬁcultyE1663R, R1764E 4.94 × 104 1.59 × 10−3 33.2
E1663R, E1665R, R1764E, E1779K 6.16 × 104 2.54 × 10−3 41.2
. Discussion
In this study, we identiﬁed the minimal IgM binding region of
he DBL4 domain of TM284var1, and tested the function of amino
cid residues predicted from a PfEMP1-IgM homology model to
e involved in binding IgM. We  used deletion mutants to identify
he minimal IgM binding region comprising all of subdomain 2 of
BL4, along with adjoining regions of subdomains 1 and 3, con-
aining seven cysteine residues in total. However, testing of charged
mino acids within subdomain 2 that were predicted from homol-ogy modelling to form part of the interaction site with IgM, showed
no large effect on IgM binding when the speciﬁc amino acids were
mutated to ones bearing the opposite charge. Therefore the exist-
ing model is not supported by experimental data, and needs to be
revised.
Recent structural studies of DBL-receptor complexes have
shown that although the DBL core scaffold composed of alpha
helices is very similar between different DBL structures, there is
extensive variation in the surface exposed loops linking the helices
[21,26–28]. Many of the known receptor binding sites map  to
such variable loops [21,26–28]. This diversity may  limit the use
of homology models to predict binding residues that are present in
variable loops. X-ray crystallography provides the gold standard
for identifying contact residues between receptors and ligands.
However, this approach is currently problematic for the study of
DBL-IgM interactions, due to the large size of IgM.in preparing completely pure recombinant protein. Even after size
exclusion chromatography, multiple protein species were seen on































































Chem 2012;287:32922–39.2 J.-P. Semblat et al. / Molecular & Bio
stic secondary structure of DBL domains by CD, and all proteins
ound human IgM at nanomolar concentrations by SPR. Western
lotting indicated that the >50 kDa proteins were his-tagged, likely
epresenting the full-length protein and fragments with limited
roteolytic degradation at the C-terminus. The experiments shown
n Fig. 1 indicate that up to 138 amino acids (17 kDa) can be removed
rom the C-terminus of the construct without loss of IgM binding,
herefore it is likely that all of the DBL4 fragments in the 50–65 kDa
ange contributed to the IgM binding interactions determined by
PR. Smaller fragments at ≈25 kDa protein were also present, which
ere not his-tagged, and could either represent bacterial impuri-
ies or DBL4 fragments that were degraded at the N-terminus. In
ither case, it is unlikely that these small fragments contributed to
he IgM binding measure by SPR. This could lead to a slight under-
stimation of the binding afﬁnity measured here, because the true
oncentration of the DBL4 protein in the assay is less than the
pparent concentration used to calculate the KD values. Despite the
ncertainty introduced by the lack of completely pure protein, it is
lear from the SPR data that all the mutant proteins retained the
bility to bind human IgM at similar concentrations as the wild type.
epeated experiments with more highly puriﬁed protein prepara-
ions would be needed to determine whether there are any minor
ifferences in binding afﬁnity between the mutants and the wild
ype.
Recent work has provided some insights into the function of
fEMP1-IgM interactions. The binding of IgM to the VAR2CSA
fEMP1 variant, that plays a key role in sequestration of iRBC in the
lacenta in pregnancy malaria, has been shown to be an immune
vasion mechanism that masks the iRBC from being targeted by
arasite-speciﬁc IgG antibodies [29]. Other studies have shown that
gM binding enhances cell–cell adhesion in the context of rosette
ormation [10,15]. Whether IgM binding by P. falciparum proteins
lso results in effects on host Fc receptors or B cell receptors
emains unknown [16]. Further work is needed to gain an accurate
nderstanding of the molecular basis of DBL-IgM binding interac-
ions and their inﬂuence on Plasmodium host-parasite interactions
nd severe malaria.
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